Sixuan Li

Sixuan Li

Auto-generated profile, based on publicly available information

Sixuan Li

Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SLSixuan Li
Sixuan Li
YHYizong Hu
Yizong Hu
ALAndrew Li
Andrew Li
JLJinghan Lin
Jinghan Lin
KHKuangwen Hsieh
Kuangwen Hsieh
HMHai-Quan Mao
Hai-Quan Mao
Lipid nanoparticles (LNPs) are effective vehicles to deliver mRNA vaccines and therapeutics. It has been challenging to assess mRNA packaging characteristics in LNPs, including payload distribution and capacity, which are critical to understanding structure-property-function relationships for further carrier development. Here, we report a method based on the multi-laser cylindrical illumination confocal spectroscopy (CICS) technique to examine mRNA and lipid contents in LNP formulations at the single-nanoparticle level. By differentiating unencapsulated mRNAs, empty LNPs and mRNA-loaded LNPs via coincidence analysis of fluorescent tags on different LNP components, and quantitatively resolving single-mRNA fluorescence, we reveal that a commonly referenced benchmark formulation using DLin-MC3 as the ionizable lipid contains mostly 2 mRNAs per loaded LNP with a presence of 40%–80% empty LNPs depending on the assembly conditions. Systematic analysis of different formulations with control variables reveals a kinetically controlled assembly mechanism that governs the payload distribution and capacity in LNPs. These results form the foundation for a holistic understanding of the molecular assembly of mRNA LNPs.

5 June 2024 in ACS Nano
Verified
Journal Article
Open access
SLSixuan Li
Sixuan Li
YHYizong Hu
Yizong Hu
JLJinghan Lin
Jinghan Lin
ZSZachary Schneiderman
Zachary Schneiderman
Fangchi ShaoFangchi Shao
Fangchi Shao
TWTza-Huei Wang
Tza-Huei Wang
Lipid nanoparticles (LNP) have emerged as pivotal delivery vehicles for RNA therapeutics. Previous research and development usually assumed that LNPs are homogeneous in population, loading density, and composition. Such perspectives are difficult to examine due to the lack of suitable tools to characterize these physicochemical properties at the single-nanoparticle level. Here, we report an integrated spectroscopy-chromatography approach as a generalizable strategy to dissect the complexities of multicomponent LNP assembly. Our platform couples cylindrical illumination confocal spectroscopy (CICS) with single-nanoparticle free solution hydrodynamic separation (SN-FSHS) to simultaneously profile population identity, hydrodynamic size, RNA loading levels, and distributions of helper lipid and PEGylated lipid of LNPs at the single-particle level and in a high-throughput manner. Using a benchmark siRNA LNP formulation, we demonstrate the capability of this platform by distinguishing seven distinct LNP populations, quantitatively characterizing size distribution and RNA loading level in wide ranges, and more importantly, resolving composition-size correlations. This SN-FSHS-CICS analysis provides critical insights into a substantial degree of heterogeneity in the packing density of RNA in LNPs and size-dependent loading-size correlations, explained by kinetics-driven assembly mechanisms of RNA LNPs.

22 August 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YHYizong Hu
Yizong Hu
STStephany Yi Tzeng
Stephany Yi Tzeng
LCLeonardo Cheng
Leonardo Cheng
JLJinghan Lin
Jinghan Lin
AVAndres Villabona-Rueda
Andres Villabona-Rueda
HMHai-Quan Mao
Hai-Quan Mao
Size-dependent phagocytosis is a well-characterized phenomenon in monocytes and macrophages. However, this size effect for preferential gene delivery to these important cell targets has not been fully exploited because commonly adopted stabilization methods for electrostatically complexed nucleic acid nanoparticles, such as PEGylation and charge repulsion, typically arrest the vehicle size below 200 nm. Here, we bridge the technical gap in scalable synthesis of larger submicron gene delivery vehicles by electrostatic self-assembly of charged nanoparticles, facilitated by a polymer structurally designed to modulate internanoparticle Coulombic and van der Waals forces. Specifically, our strategy permits controlled assembly of small poly(β-amino ester)/messenger ribonucleic acid (mRNA) nanoparticles into particles with a size that is kinetically tunable between 200 and 1,000 nm with high colloidal stability in physiological media. We found that assembled particles with an average size of 400 nm safely and most efficiently transfect monocytes following intravenous administration and mediate their differentiation into macrophages in the periphery. When a CpG adjuvant is co-loaded into the particles with an antigen mRNA, the monocytes differentiate into inflammatory dendritic cells and prime adaptive anticancer immunity in the tumor-draining lymph node. This platform technology offers a unique ligand-independent, particle-size-mediated strategy for preferential mRNA delivery and enables therapeutic paradigms via monocyte programming.

2 March 2020 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
SLSixuan Li
Sixuan Li
ZCZhigang Cui
Zhigang Cui
Yuxin ZhaoYuxin Zhao
Yuxin Zhao
SMShuwen Ma
Shuwen Ma
YSYinghui Sun
Yinghui Sun
ZYZhihua Yin
Zhihua Yin

16 January 2026 in Advanced Functional Materials
Verified
Journal Article
Closed access
TPTurash Haque Pial
Turash Haque Pial
SLSixuan Li
Sixuan Li
JLJinghan Lin
Jinghan Lin
TWTza‐Huei Wang
Tza‐Huei Wang
HMHai‐Quan Mao
Hai‐Quan Mao
TCTine Curk
Tine Curk

28 November 2023 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
FSFangchi Shao
Fangchi Shao
HLHui Li
Hui Li
KHKuangwen Hsieh
Kuangwen Hsieh
PZPengfei Zhang
Pengfei Zhang
SLSixuan Li
Sixuan Li
TWTza-Huei Wang
Tza-Huei Wang
Antimicrobial resistance (AMR) has become a global health crisis in need of novel solutions. To this end, antibiotic combination therapies, which combine multiple antibiotics for treatment, have attracted significant attention as a potential approach for combating AMR. To facilitate advances in antibiotic combination therapies, most notably in investigating antibiotic interactions and identifying synergistic antibiotic combinations however, there remains a need for automated high-throughput platforms that can create and examine antibiotic combinations on-demand, at scale, and with minimal reagent consumption. To address these challenges, we have developed a Robotic-Printed Combinatorial Droplet (RoboDrop) platform by integrating a programmable droplet microfluidic device that generates antibiotic combinations in nanoliter droplets in automation, a robotic arm that arranges the droplets in an array, and a camera that images the array of thousands of droplets in parallel. We further implement a resazurin-based bacterial viability assay to accelerate our antibiotic combination testing. As a demonstration, we use RoboDrop to corroborate two pairs of antibiotics with known interactions and subsequently identify a new synergistic combination of cefsulodin, penicillin, and oxacillin against a model E. coli strain. We therefore envision RoboDrop becoming a useful tool to efficiently identify new synergistic antibiotic combinations toward combating AMR.